National Institutes of Health at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
National Institutes of Health brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on where rAAV inserts itself into the genome. It covers how integrations that caused harm in mice pointed to the same mechanism later seen in humans, alongside integrating vector biology more broadly.
| Organization | ESGCT 2026 Attendance |
|---|---|
National Institutes of Health Bethesda, MD | |
US federal agency that funds and conducts biomedical research, including gene and cell therapy. | Poster Wed Oct 28 1:30pm–3:30pm Genotoxic rAAV integrations in mice predicted the mechanism of genotoxic rAAV integrations in humans Talk Thu Oct 29 4:30pm–6:00pm SESSION 9b: Lentiviral vectors/integrative vectors Vectors and delivery (AAV, lentiviral, LNP) |
Instantly find 20 buyers from National Institutes of Health
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction